2007 Access Clinical Trials 
NORML
APRIL 8, 2020
The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes. In 2007, the agency lost yet another lawsuit.
NORML
MARCH 1, 2019
… Without access to an expanded range of cannabis products engineered under FDA-approved Good Manufacturing Practices, scientific research cannot hope to keep pace with the ever expanding recreational and medicinal cannabis marketplace.” ” The APA represents nearly 120,000 researchers and clinicians. .”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 6, 2021
Professor Allan Young, Head of Academic Psychiatry at King’s IoPPN, said, “We have been in partnership with SLaM at the Maudsley Biomedical Research Centre since 2007, and with COMPASS on COMP360 psilocybin therapy research since 2018. London, UK – 5 July 2021.
Cannabis Law Report
JULY 6, 2021
He was also listed in “Best Doctors in America” in 2007, 2009, and 2010. He served on the National Advisory Council for NIH/NIDA from 2004 – 2007 and was a member of the Medications Development Subcommittee of NIDA’s Advisory Council on Drug Abuse during the same period. ” About Ehave, Inc. Ehave, Inc.
Canna Care Docs
DECEMBER 11, 2018
Ultimately, beyond increased access, a big reason that seniors are turning to cannabis is that it helps with a range of health issues. Accessed December 5 2018. Accessed December 5 2018. But what explains this turnaround, and what do seniors need to be aware of when it comes to medical cannabis? Let’s take a closer look.
Otherside Farms
JANUARY 23, 2019
full – 2007). Cannabis compound cannabidiol CBD ‘halts cancer’ & may bring relive to other illness’s (news – 2007). news – 2007). news – 2007). Cannabis Compound May Stop Metastatic Breast Cancer (news – 2007). news – 2007). full – 2007).
Cannabis Law Report
FEBRUARY 10, 2022
Congress passed the RTT Act in 2018 to give qualifying patients access to investigational drugs outside of a clinical trial setting. Psilocybin successfully completed an FDA-approved Phase 1 clinical trial in 2019, and two companies, COMPASS Pathways and Usona, both currently have Phase 2 trials ongoing.
Expert insights. Personalized for you.
348 
Let's personalize your content